 Pyxant 

Articles

With so many outsourcing/insourcing options across drug development workflows, pharmaceutical companies are faced with finding the right partner to fit the needs of their unique molecule. There are criteria to consider when outweighing the benefits and risks associated with buying or building a bioanalytical lab. 

Buy vs. Build: Bioanalytical lab

Spatial bioanalysis is a unique solution that can help you quickly and efficiently generate quality and unique data to file an IND.

Validating the efficacy of a compound with spatial imaging

It’s crucial to follow strict guidelines for importing and exporting biological samples to ensure your drug discovery program’s timeline stays on track. Too often, mistakes are made that result in costly delays, handling mishaps and project rework. 

Importing and exporting biological samples: Do's and don'ts

The significance of oligonucleotides (OGNTs) in drug development is increasing rapidly, as they offer promising and life-changing treatments that can improve patients' lives. Within bioanalysis, there are five main approaches to consider, each of which has its advantages and disadvantages.

Common approaches to bioanalysis of oligonucleotides

In bioanalysis, the future of small and large molecules offers exciting prospects for advancements in drug discovery, diagnostics, and therapeutics. With emerging technologies and larger substances, drug developers are faced with both new opportunities and challenges. 

The future of small and large molecule bioanalytics - today

Mass spectrometry imaging (MSI) is beneficial in early development and murine models across many therapeutic areas. This technique is especially suited for oncology due to the availability of tissue.  